Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

F1000 Research Ltd full text link F1000 Research Ltd Free PMC article
Full text links

Actions

.2019 Jul 19:8:1135.
doi: 10.12688/f1000research.19140.1. eCollection 2019.

Iron Hack - A symposium/hackathon focused on porphyrias, Friedreich's ataxia, and other rare iron-related diseases

Affiliations

Iron Hack - A symposium/hackathon focused on porphyrias, Friedreich's ataxia, and other rare iron-related diseases

Gloria C Ferreira et al. F1000Res..

Abstract

Background: Basic and clinical scientific research at the University of South Florida (USF) have intersected to support a multi-faceted approach around a common focus on rare iron-related diseases. We proposed a modified version of the National Center for Biotechnology Information's (NCBI) Hackathon-model to take full advantage of local expertise in building "Iron Hack", a rare disease-focused hackathon. As the collaborative, problem-solving nature of hackathons tends to attract participants of highly-diverse backgrounds, organizers facilitated a symposium on rare iron-related diseases, specifically porphyrias and Friedreich's ataxia, pitched at general audiences.Methods: The hackathon was structured to begin each day with presentations by expert clinicians, genetic counselors, researchers focused on molecular and cellular biology, public health/global health, genetics/genomics, computational biology, bioinformatics, biomolecular science, bioengineering, and computer science, as well as guest speakers from the American Porphyria Foundation (APF) and Friedreich's Ataxia Research Alliance (FARA) to inform participants as to the human impact of these diseases.Results: As a result of this hackathon, we developed resources that are relevant not only to these specific disease-models, but also to other rare diseases and general bioinformatics problems. Within two and a half days, "Iron Hack" participants successfully built collaborative projects to visualize data, build databases, improve rare disease diagnosis, and study rare-disease inheritance.Conclusions: The purpose of this manuscript is to demonstrate the utility of a hackathon model to generate prototypes of generalizable tools for a given disease and train clinicians and data scientists to interact more effectively.

Keywords: Ataxia; Bioinformatics; Clinical Informatics; Data Science; Friedreich’s Ataxia; Hackathon; Porphyria; Rare Diseases.

Copyright: © 2019 Ferreira GC et al.

PubMed Disclaimer

Conflict of interest statement

No competing interests were disclosed.

Figures

Figure 1.
Figure 1.. UPWARD - Uniting People Working Against Rare Disease.
UPWARD opens with a web interface designed to clearly communicate research and advocacy goals to the public, request consent and gather data in a HIPPA-compliant manner.
Figure 2.
Figure 2.. Overview of the Variants Discovery pipeline to report possible pathogenic variants associated with Mendelian diseases.
Abbreviations: dbNSFP, database for nonsynonymous SNPs’ functional predictions; WGSA, whole genome sequencing annotator; HGMD, Human gene mutation database; eQTL, expression quantitative trait loci.
Figure 3.
Figure 3.. Flowchart for Massiveseq Methodology.
The pipeline takes metadata from the Sequence Read Archive (SRA) and parses it for quality control (QC). The primary work takes place in a custom snakemake script that aligns sequences with Hisat2 and then quantifies transcripts with Stringtie in a parallelized fashion across available machines and cores.
Figure 4.
Figure 4.. The work flow chart for identifying abnormal genes based on RNA-Seq.
After RNA-Seq is performed on a patient sample, the program searches the Genotype-Tissue Expression Project (GTEx) database for RNA-Seq data from the specific tissue potentially associated with the disease. Three methods are used for RNA-Seq normalization (Fragments per kilobase of transcript per million mapped reads (FPKM), transcripts per million mapped reads (TPM) and Differential gene expression analysis based on the negative binomial distribution (as implemented in DESeq)), and the data were fit to a Gaussian mixture model to remove noise within samples. The differentially expressed genes in the patient sample are finally captured by using the R program DESeq.
Figure 5.
Figure 5.. Phenotype-to-Genotype Mapping: Assessing combinatorial variant-contribution to disease phenotypes general workflow.
Input data are variant-call files in .vcf format collected from patient samples. The feature-selection module collects all available annotation information for each identified variant, then narrows down to variants most likely to be associated with the phenotype based on user-specified parameters. These feature-selected variants are then analyzed for combinatorial contribution to the disease using the tools in the analysis module. The output of the analysis modules are tables and graphs that summarize the results.
Figure 6.
Figure 6.. Expression change of the UROS gene caused by eQTL SNP No. 1 across all tissue types in the Genotype-Tissue Expression Project (GTEx).
There is significant down-regulation of UROS gene associated with this variant in all tissues (except ovary). NES: normalized effect size.
Figure 7.
Figure 7.. Expression change of the UROS gene caused by eQTL SNP No. 2 across all tissue types in the Genotype-Tissue Expression Project (GTEx).
There is significant down-regulation of UROS gene associated with this variant in all tissues (except ovary). NES: normalized effect size.
Figure 8.
Figure 8.. Significance of up-regulated genes from metaseq analysis; red bar denotes .05 significance cutoff.
Distribution of significance in downregulated genes from metaseq analysis; no genes were significant at 0.05 threshold.
Figure 9.
Figure 9.. n = 20 genes are sampled here to compare different normalization method: Fragments per kilobase of transcript per million mapped reads (FPKM), transcripts per million mapped reads (TPM) and Differential gene expression analysis based on the negative binomial distribution (DESeq).
Figure 10.
Figure 10.. The Gaussian mixture model is implemented here to filter out noise.
Hist plot shows the distribution of gene expression level for gene ‘CELSR2’ in 1671 different brain RNA-Seq samples. The Gaussian mixture model is fitted by the EM algorithm and the noise is filtered out by posterior probability bigger than 0.5.
Figure 11.
Figure 11.. Differential gene expression analysis based on the negative binomial distribution (DESeq) is used here to find differential expression genes between patient and database.
A) Scatter plot shows significant differential genes (green dot, p-adj < 0.01).B) Boxplot shows top 10 abnormal genes in simulation compared with data from database.
See this image and copyright information in PMC

References

    1. Cook A, Giunti P: Friedreich’s ataxia: clinical features, pathogenesis and management.Br Med Bull. 2017;124(1):19–30. 10.1093/bmb/ldx034 - DOI - PMC - PubMed
    1. Balwani M, Desnick RJ: The porphyrias: advances in diagnosis and treatment.Blood. 2012;120(23):4496–4504. 10.1182/blood-2012-05-423186 - DOI - PMC - PubMed
    1. Karim Z, Lyoumi S, Nicolas G, et al. : Porphyrias: A 2015 update.Clin Res Hepatol Gastroenterol. 2015;39(4):412–425. 10.1016/j.clinre.2015.05.009 - DOI - PubMed
    1. Richter T, Nestler-Parr S, Babela R, et al. : Rare Disease Terminology and Definitions-A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group.Value Health. 2015;18(6):906–914. 10.1016/j.jval.2015.05.008 - DOI - PubMed
    1. Bissell DM, Anderson KE, Bonkovsky HL: Porphyria.N Engl J Med. 2017;377(9):862–872. 10.1056/NEJMra1608634 - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

Full text links
F1000 Research Ltd full text link F1000 Research Ltd Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2026 Movatter.jp